NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Refractory Reflux Esophagitis
Date of first enrollment	09/01/2013
Target sample size	3750
Countries of recruitment
Study type	Observational
Intervention(s)	investigational material(s) Generic name etc : Pariet INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	-Health related QOL -Symptoms of GERD Number of subjects with improvement based on health related Quality of Life (QOL) questionnaire
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	-Proton pump inhibitor-resistant reflux esophagitis. (Patients who have mucosal breaks (erosions, ulcers) on endoscopy)
Exclude criteria	-Patients with a history of hypersensitivity to any ingredients of PARIET. -Patients on atazanavir sulfate.